Here are five observations:
1. The patient has improved, going from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury, between discharge and the one-month follow-up.
2. The study has now seen a 54.5 percent conversion rate among the 11 enrolled patients.
3. The patient enrolled in the INSPIRE study at Charlotte, N.C.-based Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation in December 2016.
4. Domagoj Coric, MD, and Samuel Chewning, MD, implanted the Neuro-Spinal Scaffold in the patient.
5. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
More articles on devices:
Hip, knee orthopedic surgical implants to surge to $33B by 2022; Zimmer Biomet dominating market — 5 things to know
Bioventus appoints John Nosenzo new chief commercial officer: 7 thoughts
Xtant Medical CEO Dan Goldberger resigns: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
